Additional Information
Short Description: |
Kinase inhibitor |
Research Area: |
Cell Signaling, Cancer, Apoptosis, Cancer Growth Inhibitors, Tyrosine Kinase Inhibitors |
Alternative Name(s): |
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide |
Category: |
Small Molecules |
Product Type: |
Inhibitor |
CAS No.: |
302962-49-8 |
Molecular Formula: |
C22H26ClN7O2S |
Molecular Weight: |
488 |
Source: |
Synthetic |
Purity: |
≥98% |
Solubility: |
Soluble in DMSO (200 mg/ml), ethanol (very poorly ), and water (very poorly ) |
Appearance: |
Crystalline solid |
Storage: |
-20ºC |
Shipping: |
Shipped Ambient |
SMILES: |
C1=C(SC(=N1)NC2=CC(=NC(=N2)C)N3CCN(CC3)CCO)C(=O)NC4=C(C=CC=C4Cl)C |
InChI: |
InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27) |
InChIKey: |
ZBNZXTGUTAYRHI-UHFFFAOYSA-N |
Field of Use: |
For in vitro research use only. |
Related Products
EZSolution™ Dasatinib | 2029
26
NULL380.00
A 100 mM (25 mg in 512 µl) solution of Dasatinib (Cat. No. 1586-25) in anhydrous DMSO.EZSolution™ Dasatinib is a 100 mM (25 mg in 512 µl) solution of Dasatinib (Cat. No. 1586-25) in anhydrous DMSO...
26-2029-GEN
Dasatinib, >99% | BC023-500
495
NULL265.00
Dasatinib, >99% | BC023-500 | Gentaur UK, US & Europe Distribution
495-BC023-500
Dasatinib, >99% | BC023-101
495
NULL353.00
Dasatinib, >99% | BC023-101 | Gentaur UK, US & Europe Distribution
495-BC023-101
Dasatinib (BMS-354825) | E1KS1021
426
NULL405.00
Dasatinib (BMS-354825) | E1KS1021 | Gentaur UK, US & Europe Distribution
426-E1KS1021
Dasatinib (BMS-354825, Sprycel) | 1586
26
NULL584.00
Dasatinib is a multi-kinase inhibitor with potent activity against BCR–ABL kinase (IC₅₀ <1 nM) and Src family kinases (IC₅₀ = 0.2–1.1 nM). Dasatinib also inhibits Lyn (IC₅₀ = 8.5 nM) and Src (IC₅₀...
26-1586-GEN
